CRISPR-Cas9 (Active) protein (NLS)
-
- Antigène
- CRISPR-Cas9
- Type de proteíne
- Recombinant
- Activité biologique
- Active
-
Origine
- Streptococcus pyogenes
-
Source
- Escherichia coli (E. coli)
- Purification/Conjugué
- NLS
- Application
- Genome Editing with Engineered Nucleases (GEEN), Electrophoresis (EP)
- Fonction
- Cas9-C-NLS nuclease
- Attributs du produit
-
Recombinant Streptococcus pyogenes Cas9 (wt) protein expressed in an E. coli with a C-terminal nucleic localization signal (NLS).
- Purification
- E. coli expression system
- niveau d'endotoxine
- < 0.1 eu/μg
- Biological Activity Comment
- 20 nM CRISPR/Cas9-C-NLS nuclease incubated for 1 hour at 37℃ result in 90% digestion of the substrate DNA as determined by agarose gel electrophoresis.
-
-
- Indications d'application
-
CRISPR Genome editing
The optimal working dilution should be determined by the end user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- In 10 mM Tris, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 50 % Glycerol PH 7.4
- Agent conservateur
- Dithiothreitol (DTT)
- Précaution d'utilisation
- This product contains Dithiothreitol (DTT): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
-
- Antigène
- CRISPR-Cas9
- Autre désignation
- Cas9 nuclease
-